Sign In
Buy HIMS
$32.16
+1.34 (+4.35%)
At Close: Aug 04, 2026
Wall Street's Most Wanted: 2 Highly Shorted Stocks Right Now
08:45am, Wednesday, 26'th Feb 2025
Short-selling is an interesting part of the stock market that can be dangerous and even controversial. Investors selling shares short are hoping that the price of certain stocks falls so that they can
Hims & Hers Health: Focus On The Future, Not GLP-1s
02:22pm, Tuesday, 25'th Feb 2025
Hims & Hers Health, Inc. reported strong growth, with Q4 sales up $80 million sequentially, yet HIMS stock fell due to GLP-1 business confusion. The online health and wellness platform guided to $2.3
HIMS Stock Craters – Is It a Buying Opportunity?
12:41pm, Tuesday, 25'th Feb 2025
Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn't guarantee it would be able to continue se
HIMS Stock Declines Following Q4 Earnings Miss, Gross Margin Contracts
12:10pm, Tuesday, 25'th Feb 2025
Hims & Hers' revenue channels witness strong growth on the back of solid product demand in the fourth quarter.
Hims Stock Crashed After Earnings. What Went Wrong?
11:51am, Tuesday, 25'th Feb 2025
In this video, I will go over the fourth-quarter earnings report from Hims & Hers (HIMS -27.60%) and explain why the stock crashed on Tuesday. Watch the short video to learn more, consider subscribin
Hims & Hers Stock Crashed 26% Today. Here's What You Need to Know
11:45am, Tuesday, 25'th Feb 2025
Hims & Hers (HIMS -27.66%) continues to grow at an astounding rate as the company grows subscribers and revenue per subscriber. But Hims & Hers stock is falling after earnings because investors are co
Hims & Hers shares plunge 28% on concerns over weight loss business, margins
10:56am, Tuesday, 25'th Feb 2025
Hims & Hers shares fell on Tuesday, a day after the company released fourth-quarter results that disappointed on gross margin and outlined changes to its weight loss business. The company reported $48
Hims & Hers CFO talks Q4 earnings
10:52am, Tuesday, 25'th Feb 2025
Hims & Hers Health (HIMS) stock is dropping in extended hours upon the telehealth company's fourth quarter earnings release, topping revenue ($481.14 million vs. forecasts of $470.39 million) and tota
Bitcoin Concerns, SPX Upside to "$6030" & HIMS Sinks
08:54am, Tuesday, 25'th Feb 2025
As Bitcoin (/BTC) falls to 3-month lows, Kevin Green points to fundamental factors that are weighing on its price activity. He says the technical setup indicates possible selling pressure remains for
Novo Nordisk's stock is rallying as Hims & Hers' stock falters. An Ozempic alternative won't be available for long.
07:29am, Tuesday, 25'th Feb 2025
Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won't be selling it for much longer.
Hims & Hers shares drop on doubts over weight-loss business forecast
07:21am, Tuesday, 25'th Feb 2025
Shares of Hims & Hers Health tumbled 18% premarket on Tuesday as Wall Street analysts questioned the telehealth provider's lofty sales forecast in the face of looming restrictions on compounded weight
Hims & Hers: Capitalizing On The GLP-1 Rush Before The Window Closes (Rating Upgrade)
06:47am, Tuesday, 25'th Feb 2025
I expect price sensitive consumers to flood the market for compounded GLP-1 drugs before the 60-day FDA grace period for semaglutide compounders. HIMS projects $725M in GLP-1 weight loss revenue for 2
Hims & Hers Earnings: Very Strong Business, In A Very Crowded Trade
04:20am, Tuesday, 25'th Feb 2025
Hims & Hers experienced a sell-off due to profit-taking and weaker-than-expected EBITDA margins, despite strong revenue growth. The company is projected to generate over $2 billion in revenues and $35
Hims & Hers: Why This Q4 Earnings Dip Is A Buying Opportunity
04:01am, Tuesday, 25'th Feb 2025
Hims & Hers stock fell ~19% post-Q4 earnings despite revenue beating expectations and EPS aligning with estimates, attributed to gross margin concerns and potential dependency on GLP-1 for future grow
Hims & Hers CFO, drone regulation: Asking for a Trend
10:49pm, Monday, 24'th Feb 2025
Josh Lipton takes a closer look at the top stories investors need to know after the closing bell on Asking for a Trend. Hims & Hers Health (HIMS) CFO Yemi Okupe breaks down the quarterly results as sh
